China Pharma Holdings (CPHI) Short-term Investments (2013 - 2019)
China Pharma Holdings' (CPHI) quarterly Short-term Investments came in at $109908.0 in Q4 2019, down 99.75% on a QoQ basis from $43.1 million in Q2 2015.
China Pharma Holdings (CPHI) Short-term Investments (2013 - 2019) Analysis & Trends
China Pharma Holdings (CPHI) has 4 years of Short-term Investments data on file, last reported at $109908.0 in Q4 2019.
- Quarterly Short-term Investments changed N/A year-over-year to $109908.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $109908.0 (changed N/A YoY) and the FY2019 annual result came in at $109908.0, changed N/A from the prior year.
- Short-term Investments fell to $109908.0 in Q4 2019, from $43.1 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $43.1 million in Q2 2015 to a low of $109908.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | China Pharma Holdings | 41.74 Mn | 41.44 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 109,908.00 |
| Jun 30, 2015 | 43.14 Mn |
| Dec 31, 2014 | 42.39 Mn |
| Dec 31, 2013 | 41.70 Mn |